Gilead Sciences Announces Price Tag For Coronavirus Drug Remdesivir

Newsy Monday, 29 June 2020 ()
Gilead Sciences Announces Price Tag For Coronavirus Drug RemdesivirWatch VideoThe maker of the COVID-19 drug remdesivir announced it's pricing its antiviral medication at $520 a dose for most U.S. patients.

On Monday, drug maker Gilead Sciences said that comes out to $3,120 for patients with private insurance for a "typical" five-day treatment course of six vials.

For the rest of the...
0
shares
 
Video credit: GeoBeats - Published
News video: Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient

Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient 00:44

 Gilead Sciences announced on Monday that it has set a price for Remdesivir, a drug that’s shown success in reducing the duration of some COVID-19 cases.